Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine Plus Progesterone for Early Endometrial Carcinoma
NCT06942377Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlodipine in endometrial carcinoma, sponsored by Peking University People's Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
amlodipine
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT06942377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06942377.